ImmunoForge to Accelerate CNS Drug Development with Innovative BBB Shuttle Platform 'LMT15' - Thailand PR News - [Banking](https://thailandbusinessnews.net/category/banking/) - [Companies](https://thailandbusinessnews.net/category/companies/) - [Economy](https://thailandbusinessnews.net/category/economy/) - [Press Releases](https://thailandbusinessnews.net/category/press-release/) - [PR Newswire](https://thailandbusinessnews.net/pr-newswire-updates/) - [Tech](https://thailandbusinessnews.net/category/tech/) - [Tourism](https://thailandbusinessnews.net/category/tourism/) - [Press Release](https://thailandbusinessnews.net/category/press-release/) # ImmunoForge to Accelerate CNS Drug Development with Innovative BBB Shuttle Platform 'LMT15' ##### Up next ![Lingnan ICH Shines on the Global Haute Couture Stage: One Heung Kong and Guangdong Fashion Week Forge a New Paradigm for Chinese Original Design](https://i0.wp.com/mma.prnasia.com/media2/2962883/image1.jpg?resize=200%2C110&ssl=1 "Lingnan ICH Shines on the Global Haute Couture Stage: One Heung Kong and Guangdong Fashion Week Forge a New Paradigm for Chinese Original Design") [](https://thailandbusinessnews.net/press-release/lingnan-ich-shines-on-the-global-haute-couture-stage-one-heung-kong-and-guangdong-fashion-week-forge-a-new-paradigm-for-chinese-original-design/) ###### [Lingnan ICH Shines on the Global Haute Couture Stage: One Heung Kong and Guangdong Fashion Week Forge a New Paradigm for Chinese Original Design](https://thailandbusinessnews.net/press-release/lingnan-ich-shines-on-the-global-haute-couture-stage-one-heung-kong-and-guangdong-fashion-week-forge-a-new-paradigm-for-chinese-original-design/) Published on 22 April 2026 ##### Author ##### [ CISION PRNewswire ](https://thailandbusinessnews.net/author/cision/) ##### Tags - [PRNewswire](https://thailandbusinessnews.net/tag/prnewswire/) ![](https://mma.prnasia.com/media2/2596347/Immunoforge_Logo.jpg?p=medium600 "logo")- **ImmunoForge’s LMT15 Platform combines high BBB permeability with proprietary long-acting ELP technology** - **Technology excellence validated by winning first place at ‘Novo Nordisk Partnering Day Korea 2026’** SEOUL, South Korea, April 22, 2026 /PRNewswire/ — ImmunoForge Co., Ltd., a clinical-stage biopharmaceutical company specializing in treatments for rare and muscular diseases, is poised to redefine Central Nervous System (CNS) drug delivery with its proprietary **LMT15 Platform**, a next-generation Blood-Brain Barrier (BBB) shuttle technology. The **LMT15 Platform** is based on Leptin receptor-Mediated Transcytosis (LMT), offering a significant competitive edge over existing BBB penetration technologies. By leveraging this specific pathway, LMT15 achieves **superior permeability into the brain while minimizing potential side effects**. A key differentiator of LMT15 is its integration with ImmunoForge’s core **ELP (Elastin-Like Polypeptide) technology**. This unique fusion allows for a single-structure modality that provides both efficient BBB penetration and a **once-monthly long-acting formulation**. This dual-functionality is expected to have transformative applications in the development of CNS-targeted therapies and long-acting obesity medications. The innovative potential of LMT15 was recently recognized on a global stage. **ImmunoForge announced that it was awarded first place at ‘Novo Nordisk Partnering Day 2026’**, an open innovation event co-hosted by Novo Nordisk Pharma Korea, the Korea Health Industry Development Institute (KHIDI), and Novo Holdings on April 1st. Out of numerous domestic biotech and healthcare participants, ImmunoForge secured the top spot following a rigorous preliminary review and final pitching session. As a winner, ImmunoForge will receive expert feedback, investment mentoring, and collaboration networking opportunities from Novo Nordisk and Novo Holdings, further validating its technological prowess and market readiness. "Our LMT15 platform represents a breakthrough in overcoming the challenges of brain drug delivery," said **Kiho Chang, Co-CEO of ImmunoForge**. "Building on the recognition from Novo Nordisk, we are actively seeking joint research and global technology transfer opportunities. Our goal is to collaborate with partners worldwide to apply our ELP and LMT15 platforms to a wide range of CNS and metabolic disease candidates." Earlier this year, ImmunoForge filed for a patent for LMT15 and is now initiating full-scale development for its CNS pipeline. Beyond its platform technologies, ImmunoForge continues to advance its clinical-stage assets: - **PF1801:** Currently in Phase 2 clinical trials for Polymyositis (PM) and Dermatomyositis (DM). - **PF1804:** Developed for Duchenne Muscular Dystrophy (DMD) cardiomyopathy, it has received U.S. FDA IND approval for Phase 2 and Orphan Drug Designation (ODD). **About ImmunoForge** ImmunoForge Co., Ltd. is a clinical-stage, venture-backed biopharmaceutical company dedicated to developing innovative therapies for muscular and rare diseases. The company leverages its proprietary long-acting ELP (Elastin-Like Polypeptide) platform and the LMT15 BBB shuttle platform to extend drug half-life and enhance delivery efficiency. To date, ImmunoForge has successfully raised approximately $32 million in cumulative investment, underscoring strong investor confidence in its technological potential. With a robust pipeline and strategic global partnerships, ImmunoForge is committed to bringing life-changing treatments to patients worldwide. [Source link ](http://www.prnasia.com/story/archive/4940787_CN40787_0?rand=89749) ``` This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network ``` ##### You May Also Like [](https://thailandbusinessnews.net/press-release/infortrend-recognized-in-crns-storage-100-as-one-of-the-50-coolest-software-defined-storage-vendors-for-2026/) ## Infortrend Recognized in CRN's Storage 100 as One of The 50 Coolest Software-Defined Storage Vendors for 2026 TAIPEI, April 22, 2026 /PRNewswire/ — Infortrend Technology, Inc. (TWSE: 2495), a leading… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - April 22, 2026 [](https://thailandbusinessnews.net/press-release/wenge-ai-subsidiary-d2-intelligence-launches-documind-an-enterprise-document-intelligence-and-decision-platform/) ![Wenge AI Subsidiary D2 Intelligence Launches DocuMind, an Enterprise Document Intelligence and Decision Platform](https://i0.wp.com/mmx.prnasia.com/media/MS1994668/20260923022400EDT_image_1.jpg?resize=260%2C140&ssl=1 "Wenge AI Subsidiary D2 Intelligence Launches DocuMind, an Enterprise Document Intelligence and Decision Platform") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## Wenge AI Subsidiary D2 Intelligence Launches DocuMind, an Enterprise Document Intelligence and Decision Platform HONG KONG, Sept. 23, 2026 /PRNewswire/ — D2 Intelligence, a subsidiary of Wenge… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - September 23, 2026 [](https://thailandbusinessnews.net/press-release/tutorabc-expands-study-abroad-partnerships-to-over-700-universities-with-zero-consulting-fees/) ![TutorABC Expands Study Abroad Partnerships to Over 700 Universities with Zero Consulting Fees](https://i0.wp.com/mma.prnasia.com/media2/2746750/ABC_4x_Logo.jpg?resize=260%2C140&ssl=1 "TutorABC Expands Study Abroad Partnerships to Over 700 Universities with Zero Consulting Fees") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## TutorABC Expands Study Abroad Partnerships to Over 700 Universities with Zero Consulting Fees TAIPEI, March 18, 2026 /PRNewswire/ — Each year, tens of thousands of… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - March 18, 2026 ##### Most Read - [![Dragonpass: AI Is Shifting the Membership Economy from Perks Redemption to Personalized Experiences](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/dragonpass-ai-is-shifting-the-membership-economy-from-perks-redemption-to-personalized-experiences/ "Dragonpass: AI Is Shifting the Membership Economy from Perks Redemption to Personalized Experiences") [Dragonpass: AI Is Shifting the Membership Economy from Perks Redemption to Personalized Experiences](https://thailandbusinessnews.net/press-release/dragonpass-ai-is-shifting-the-membership-economy-from-perks-redemption-to-personalized-experiences/ "Dragonpass: AI Is Shifting the Membership Economy from Perks Redemption to Personalized Experiences") - [![HiBy Officially Unveils Cyberpunk 2077 Collaboration Products](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/hiby-officially-unveils-cyberpunk-2077-collaboration-products/ "HiBy Officially Unveils Cyberpunk 2077 Collaboration Products") [HiBy Officially Unveils Cyberpunk 2077 Collaboration Products](https://thailandbusinessnews.net/press-release/hiby-officially-unveils-cyberpunk-2077-collaboration-products/ "HiBy Officially Unveils Cyberpunk 2077 Collaboration Products") - [![Sumsub Agentic AI Council Launches in APAC and Invites Experts to Advance Trusted AI Adoption](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/sumsub-agentic-ai-council-launches-in-apac-and-invites-experts-to-advance-trusted-ai-adoption/ "Sumsub Agentic AI Council Launches in APAC and Invites Experts to Advance Trusted AI Adoption") [Sumsub Agentic AI Council Launches in APAC and Invites Experts to Advance Trusted AI Adoption](https://thailandbusinessnews.net/press-release/sumsub-agentic-ai-council-launches-in-apac-and-invites-experts-to-advance-trusted-ai-adoption/ "Sumsub Agentic AI Council Launches in APAC and Invites Experts to Advance Trusted AI Adoption") - [![Nel ASA: Receives purchase order from Collins Aerospace for US Navy stacks](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/nel-asa-receives-purchase-order-from-collins-aerospace-for-us-navy-stacks/ "Nel ASA: Receives purchase order from Collins Aerospace for US Navy stacks") [Nel ASA: Receives purchase order from Collins Aerospace for US Navy stacks](https://thailandbusinessnews.net/press-release/nel-asa-receives-purchase-order-from-collins-aerospace-for-us-navy-stacks/ "Nel ASA: Receives purchase order from Collins Aerospace for US Navy stacks") - [![Acer Announces Q2'26 Net Income at NT$2.17 Billion, Highest Quarter Post Pandemic; Up 100.2% Year-on-year](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/acer-announces-q226-net-income-at-nt2-17-billion-highest-quarter-post-pandemic-up-100-2-year-on-year/ "Acer Announces Q2'26 Net Income at NT$2.17 Billion, Highest Quarter Post Pandemic; Up 100.2% Year-on-year") [Acer Announces Q2'26 Net Income at NT$2.17 Billion, Highest Quarter Post Pandemic; Up 100.2% Year-on-year](https://thailandbusinessnews.net/press-release/acer-announces-q226-net-income-at-nt2-17-billion-highest-quarter-post-pandemic-up-100-2-year-on-year/ "Acer Announces Q2'26 Net Income at NT$2.17 Billion, Highest Quarter Post Pandemic; Up 100.2% Year-on-year") - [![More Than a Stylus: How Hands-On Experiences Are Changing the Way Consumer Electronics Are Presented](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/more-than-a-stylus-how-hands-on-experiences-are-changing-the-way-consumer-electronics-are-presented/ "More Than a Stylus: How Hands-On Experiences Are Changing the Way Consumer Electronics Are Presented") [More Than a Stylus: How Hands-On Experiences Are Changing the Way Consumer Electronics Are Presented](https://thailandbusinessnews.net/press-release/more-than-a-stylus-how-hands-on-experiences-are-changing-the-way-consumer-electronics-are-presented/ "More Than a Stylus: How Hands-On Experiences Are Changing the Way Consumer Electronics Are Presented") ##### Subscribe via Email Enter your email address to subscribe and receive notifications of new posts by email. Email Address Subscribe [](https://thailandbusinessnews.net/press-release/hainan-highlights-distinctive-draws-for-hong-kong-visitors/) ![Hainan highlights distinctive draws for Hong Kong visitors](https://i0.wp.com/mmx.prnasia.com/media/MS1999693/20260930081032EDT_image_1.jpg?resize=260%2C140&ssl=1 "Hainan highlights distinctive draws for Hong Kong visitors") ## Hainan highlights distinctive draws for Hong Kong visitors BEIJING, Sept. 30, 2026 /PRNewswire/ — A report from China Daily. Tourism… [](https://thailandbusinessnews.net/press-release/macao-hainan-explore-multi-stop-travel-itineraries/) ![Macao, Hainan explore multi-stop travel itineraries](https://i0.wp.com/mmx.prnasia.com/media/MS1999672/20260930074825EDT_image_1.jpg?resize=260%2C140&ssl=1 "Macao, Hainan explore multi-stop travel itineraries") ## Macao, Hainan explore multi-stop travel itineraries BEIJING, Sept. 30, 2026 /PRNewswire/ — A report from China Daily. Tourism… [](https://thailandbusinessnews.net/press-release/zhendong-pharmaceutical-announces-publication-of-phase-iib-study-of-investigational-vaginal-lactobacillus-capsule-in-the-national-medical-journal-of-china/) ## Zhendong Pharmaceutical Announces Publication of Phase IIb Study of Investigational Vaginal Lactobacillus Capsule in the National Medical Journal of China BEIJING, Sept. 30, 2026 /PRNewswire/ — Zhendong Pharmaceutical announced that… [](https://thailandbusinessnews.net/press-release/zhongchao-inc-announces-1-for-2-share-consolidation/) ## Zhongchao Inc. Announces 1-for-2 Share Consolidation SHANGHAI, Sept. 30, 2026 /PRNewswire/ — Zhongchao Inc. (NASDAQ: ZCMD)…